Immunovant (IMVT) CTO sells 2,857 shares in mandated tax sell-to-cover
Rhea-AI Filing Summary
Immunovant, Inc. reports that Chief Technology Officer Jay S. Stout sold 2,857 shares of common stock on July 23, 2026 at a weighted average price of $38.69 per share, with sale prices ranging from $38.18 to $39.05. The shares were sold to cover tax withholding obligations from the July 17, 2026 vesting of 6,250 restricted stock units from a 100,000-unit grant. After this mandated sell-to-cover transaction, he directly holds 205,341 shares of Immunovant common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 2,857 shares
Net Sell
1 txn
Insider
Stout Jay S
Role
Chief Technology Officer
Sold
2,857 shs ($111K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 2,857 | $38.69 | $111K |
Holdings After Transaction:
Common Stock — 205,341 shares (Direct)
Footnotes (2)
- F1. On April 17, 2023, the holder was granted 100,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on July 17, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.18 - $39.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Key Figures
Shares sold: 2,857 shares
Weighted average sale price: $38.69 per share
Post-transaction holdings: 205,341 shares
+3 more
6 metrics
Shares sold
2,857 shares
Common stock sold on July 23, 2026 to cover tax withholding
Weighted average sale price
$38.69 per share
Weighted average for multiple sale transactions between $38.18 and $39.05
Post-transaction holdings
205,341 shares
Directly held Immunovant common shares following the reported sale
RSU grant size
100,000 RSUs
Restricted stock units granted on April 17, 2023
RSUs vested
6,250 RSUs
Portion of the RSU grant that vested on July 17, 2026
Sale price range
$38.18–$39.05 per share
Range of individual trade prices within the reported sale
Key Terms
restricted stock units, sell to cover, weighted average price, tax withholding obligations
4 terms
restricted stock units financial
"the holder was granted 100,000 restricted stock units ("RSUs")"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
sell to cover financial
"tax withholding obligations to be funded by a "sell to cover" transaction"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
weighted average price financial
"The price reported is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
tax withholding obligations financial
"shares sold by the Reporting Person to cover tax withholding obligations"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction involving Immunovant (IMVT) was reported?
Chief Technology Officer Jay S. Stout sold 2,857 shares of Immunovant common stock on July 23, 2026 at a weighted average price of $38.69 per share. The transaction was linked to the vesting of previously granted restricted stock units and was used to satisfy tax obligations.